FDA Drug recall D-1285-2015
Desmopressin Acetate Tablets, 0.1mg, 100 Count Bottles, Rx Only
- FDA Drug
- Class III
- terminated
- Published 2015-08-12
On 2015-08-12 the FDA classified a Class III recall of Desmopressin Acetate Tablets, 0.1mg, 100 Count Bottles, Rx Only by Actavis Laboratories Fl, citing tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1285-2015 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2015-06-23 |
| Published | 2015-08-12 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Actavis Laboratories Fl |
| Distribution | US |
Product
Desmopressin Acetate Tablets, 0.1mg, 100 Count Bottles, Rx Only. Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA; Distributed by Actavis Pharma, Inc. Parsippany, NJ 07054 USA. NDC: 0591-2464-01.
Reason
Tablets/Capsules Imprinted with Wrong ID: Some tablets incorrectly imprinted with an X on one side.
Identifiers
| code_info | Lot # 982021M, Expiry: DEC. 2016 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1285-2015%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.